{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:12:33Z","timestamp":1792743153473,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["1402-2-113-26934"],"award-info":[{"award-number":["1402-2-113-26934"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40272-024-00644-8","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T14:05:05Z","timestamp":1721743505000},"page":"519-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Esmaeel","family":"Toni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Ayatollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Abbaszadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Fotuhi Siahpirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"644_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101249","volume":"43","author":"Z Su","year":"2022","unstructured":"Su Z, Zou Z, Hay SI, Liu Y, Li S, Chen H, et al. Global, regional, and national time trends in mortality for congenital heart disease, 1990\u20132019: An age-period-cohort analysis for the global burden of disease 2019 study. EClinicalMedicine. 2022;43: 101249.","journal-title":"EClinicalMedicine."},{"issue":"2","key":"644_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/bdr2.1980","volume":"114","author":"EB Stallings","year":"2022","unstructured":"Stallings EB, Isenburg JL, Aggarwal D, Lupo PJ, Oster ME, Shephard H, et al. Prevalence of critical congenital heart defects and selected co-occurring congenital anomalies, 2014\u20132018: a U.S. population-based study. Birth Defects Res. 2022;114(2):45\u201356.","journal-title":"Birth Defects Res"},{"issue":"8","key":"644_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19188","volume":"9","author":"JP Zila-Velasque","year":"2023","unstructured":"Zila-Velasque JP, Grados-Espinoza P, Cubas WS, Diaz-Barrera M, Pacheco-Mendoza J. Analysis of congenital heart disease research: mapping impact, production and global collaboration. Heliyon. 2023;9(8): e19188.","journal-title":"Heliyon."},{"issue":"Suppl 2","key":"644_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S1047951108002801","volume":"18","author":"CI Tchervenkov","year":"2008","unstructured":"Tchervenkov CI, Jacobs JP, Bernier PL, Stellin G, Kurosawa H, Mavroudis C, et al. The improvement of care for paediatric and congenital cardiac disease across the world: a challenge for the world society for pediatric and congenital heart surgery. Cardiol Young. 2008;18(Suppl 2):63\u20139.","journal-title":"Cardiol Young"},{"issue":"6","key":"644_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","volume":"120","author":"RB Hinton","year":"2017","unstructured":"Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circ Res. 2017;120(6):978\u201394.","journal-title":"Circ Res"},{"issue":"3","key":"644_CR6","first-page":"42","volume":"6","author":"PS Rao","year":"2019","unstructured":"Rao PS. Management of congenital heart disease: state of the art; part I-acyanotic heart defects. Children (Basel). 2019;6(3):42.","journal-title":"Children (Basel)."},{"key":"644_CR7","doi-asserted-by":"crossref","unstructured":"Dabbagh A, Talebi Z, Rajaei S. Cardiovascular pharmacology in pediatric patients with congenital heart disease. In: Dabbagh A, Hernandez Conte A, Lubin LN, editors. Congenital heart disease in pediatric and adult patients: anesthetic and perioperative management. Springer International Publishing; 2023. p. 91\u2013152.","DOI":"10.1007\/978-3-031-10442-8_4"},{"key":"644_CR8","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2147\/PPA.S222176","volume":"13","author":"FL Mondesir","year":"2019","unstructured":"Mondesir FL, Levitan EB, Malla G, Mukerji R, Carson AP, Safford MM, et al. Patient perspectives on factors influencing medication adherence among people with coronary heart disease (CHD) and CHD risk factors. Patient Prefer Adherence. 2019;13:2017\u201327.","journal-title":"Patient Prefer Adherence"},{"issue":"8","key":"644_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/HCQ.0000000000000110","volume":"15","author":"AH Kovacs","year":"2022","unstructured":"Kovacs AH, Brouillette J, Ibeziako P, Jackson JL, Kasparian NA, Kim YY, et al. Psychological outcomes and interventions for individuals with congenital heart disease: a scientific statement from the American heart association. Circ Cardiovasc Qual Outcomes. 2022;15(8): e000110.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"644_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.681224","volume":"9","author":"KL Loss","year":"2021","unstructured":"Loss KL, Shaddy RE, Kantor PF. Recent and upcoming drug therapies for pediatric heart failure. Front Pediatr. 2021;9: 681224.","journal-title":"Front Pediatr"},{"issue":"3","key":"644_CR11","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2020\/38\/2018134","volume":"38","author":"ARF Nascimento","year":"2020","unstructured":"Nascimento ARF, Leopoldino RWD, Santos MET, Costa TX, Martins RR. Drug-related problems in cardiac neonates under intensive care. Rev Paul Pediatr. 2020;38(3): e2018134.","journal-title":"Rev Paul Pediatr."},{"issue":"1","key":"644_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-019-01318-x","volume":"20","author":"M Tirfe","year":"2020","unstructured":"Tirfe M, Nedi T, Mekonnen D, Berha AB. Treatment outcome and its predictors among patients of acute heart failure at a tertiary care hospital in Ethiopia: a prospective observational study. BMC Cardiovasc Disord. 2020;20(1):1\u201310.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"644_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/cpt.677","volume":"101","author":"AA Elzagallaai","year":"2017","unstructured":"Elzagallaai AA, Greff MJ, Rieder MJ. Adverse drug reactions in children: The double-edged sword of therapeutics. Clin Pharmacol Ther. 2017;101(6):725\u201335.","journal-title":"Clin Pharmacol Ther"},{"key":"644_CR14","first-page":"155","volume-title":"Goodman & Gilman's: the pharmacological basis of therapeutics","author":"AR Johnson","year":"2023","unstructured":"Johnson AR, Brown KM. Principles of clinical toxicology. In: Brunton LL, Knollmann BC, editors. Goodman & Gilman\u2019s: the pharmacological basis of therapeutics. 14th ed. New York: McGraw-Hill Education; 2023. p. 155\u201369.","edition":"14"},{"key":"644_CR15","unstructured":"Clinical safety data management: definitions and standards for expedited reporting. London: European Medicines Agency's (EMA); 1995."},{"issue":"10","key":"644_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/apa.14921","volume":"108","author":"M Brida","year":"2019","unstructured":"Brida M, Gatzoulis MA. Adult congenital heart disease: past, present and future. Acta Paediatr. 2019;108(10):1757\u201364.","journal-title":"Acta Paediatr"},{"issue":"14","key":"644_CR17","doi-asserted-by":"publisher","first-page":"e801","DOI":"10.1161\/CIR.0000000000000604","volume":"139","author":"E Zaragoza-Macias","year":"2019","unstructured":"Zaragoza-Macias E, Zaidi AN, Dendukuri N, Marelli A. Medical therapy for systemic right ventricles: a systematic review (part 1) for the 2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e801\u201313.","journal-title":"Circulation"},{"issue":"4","key":"644_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057400","volume":"12","author":"M Damkjaer","year":"2022","unstructured":"Damkjaer M, Urhoj SK, Tan J, Briggs G, Loane M, Given JE, et al. Prescription of cardiovascular medication in children with congenital heart defects across six European regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study. BMJ Open. 2022;12(4): e057400.","journal-title":"BMJ Open"},{"issue":"1","key":"644_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332.","journal-title":"Int J Soc Res Methodol"},{"issue":"7","key":"644_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"1","key":"644_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00383-023-05428-8","volume":"39","author":"UA Tandircioglu","year":"2023","unstructured":"Tandircioglu UA, Turer OB, Soyer T, Ayaz E, Ozcan HN, Yigit S, et al. Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases. Pediatr Surg Int. 2023;39(1):144.","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"644_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.hrthm.2021.11.021","volume":"19","author":"E Rochelson","year":"2022","unstructured":"Rochelson E, Valdes SO, Asadourian V, Patel R, Lemming K, Howard TS, et al. Sotalol versus amiodarone for postoperative junctional tachycardia after congenital heart surgery. Heart Rhythm. 2022;19(3):450\u20136.","journal-title":"Heart Rhythm"},{"issue":"7","key":"644_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1055\/s-0039-3400996","volume":"38","author":"S Waldvogel","year":"2021","unstructured":"Waldvogel S, Atkinson A, Wilbeaux M, Nelle M, Berger MR, Gerull R. High dose indomethacin for patent ductus arteriosus closure increases neonatal morbidity. Am J Perinatol. 2021;38(7):707\u201313.","journal-title":"Am J Perinatol"},{"issue":"1","key":"644_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/S1047951120003297","volume":"31","author":"D Vari","year":"2021","unstructured":"Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young. 2021;31(1):63\u201370.","journal-title":"Cardiol Young"},{"issue":"12","key":"644_CR25","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1097\/PEC.0000000000002472","volume":"37","author":"M van Heugten","year":"2021","unstructured":"van Heugten M, van Onzenoort-Bokken L. Sildenafil citrate overdose in a 3-month postterm premature infant with pulmonary artery hypertension. Pediatr Emerg Care. 2021;37(12):e866\u20137.","journal-title":"Pediatr Emerg Care"},{"issue":"6","key":"644_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.hrcr.2021.03.020","volume":"7","author":"CY Miyake","year":"2021","unstructured":"Miyake CY, Kim JJ, Tosur M, Howard TS, Pham TDN, Valdes SO. Severe hypoglycemia associated with oral sotalol use in two children. HeartRhythm Case Rep. 2021;7(6):418\u201321.","journal-title":"HeartRhythm Case Rep."},{"issue":"1","key":"644_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023998","volume":"100","author":"S Ming","year":"2021","unstructured":"Ming S, Xie Y, Du X, Huang H, Fan Y, Liang Q, et al. Effect of dexmedetomidine on perioperative hemodynamics and organ protection in children with congenital heart disease: a randomized controlled trial. Medicine (Baltimore). 2021;100(1): e23998.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"644_CR28","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41372-021-01046-1","volume":"41","author":"K Hillier","year":"2021","unstructured":"Hillier K, Jones K, MacInnis M, Mitra S. Comparison of standard versus high-dose ibuprofen for the treatment of hemodynamically significant patent ductus arteriosus in preterm infants. J Perinatol. 2021;41(5):1142\u20138.","journal-title":"J Perinatol"},{"issue":"1","key":"644_CR29","first-page":"63","volume":"23","author":"DG Ana Beatriz","year":"2021","unstructured":"Ana Beatriz DG, Flavia Evelyn MF, da Silva J\u00e1rdila Ravana A, Danillo Jos\u00e9 CSN, Ana Flavia DMMB, Jos\u00e9 Jorge MN, et al. Periostitis after prolonged use of alprostadil in newborns with congenital cyanotic heart disease: case reports. Eur J Clin Pharm. 2021;23(1):63\u20136.","journal-title":"Eur J Clin Pharm"},{"issue":"1","key":"644_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40199-020-00386-1","volume":"29","author":"F Afra","year":"2021","unstructured":"Afra F, Mehri M, Namazi S. Bosentan-induced immune hemolytic anemia in 17 years old man. A case report. Daru. 2021;29(1):211\u20135.","journal-title":"Daru"},{"issue":"16","key":"644_CR31","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1080\/14767058.2018.1559810","volume":"33","author":"R Vaidya","year":"2020","unstructured":"Vaidya R, Wilson D, Paris Y, Madore L, Singh R. Use of acetaminophen for patent ductus arteriosus treatment: a single center experience. J Matern Fetal Neonatal Med. 2020;33(16):2723\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"644_CR32","first-page":"12","volume":"103","author":"V Sanphasitvong","year":"2020","unstructured":"Sanphasitvong V, Tocharoenchok T. Appropriate dose of postoperative intravenous heparin infusion in the children undergoing modified blalock taussig shunt 4 mm and below in size. J Med Assoc Thail. 2020;103(5):12\u20135.","journal-title":"J Med Assoc Thail."},{"issue":"2","key":"644_CR33","volume":"2","author":"ML Avila","year":"2020","unstructured":"Avila ML, Shah PS, Brandao LR. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization. Cochrane Database Syst Rev. 2020;2(2): CD010196.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"644_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/pace.13662","volume":"42","author":"AC Hill","year":"2019","unstructured":"Hill AC, Silka MJ, Bar-Cohen Y. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Pacing Clin Electrophysiol. 2019;42(6):670\u20137.","journal-title":"Pacing Clin Electrophysiol"},{"key":"644_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ppedcard.2018.08.001","volume":"52","author":"S Covi","year":"2019","unstructured":"Covi S, Clark J, Delius R, Chauhan M. Amiodarone toxicity in two post-operative congenital heart disease patients. Prog Pediatr Cardiol. 2019;52:46\u20139.","journal-title":"Prog Pediatr Cardiol"},{"issue":"5","key":"644_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/PCC.0000000000001878","volume":"20","author":"V Boos","year":"2019","unstructured":"Boos V, Tietze A, Berger F, Buhrer C. Therapeutic hypothermia after perinatal asphyxia in infants with severe, ductal-dependent congenital heart disease. Pediatr Crit Care Med. 2019;20(5):457\u201365.","journal-title":"Pediatr Crit Care Med"},{"key":"644_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fped.2019.00361","volume":"7","author":"H Ba","year":"2019","unstructured":"Ba H, Xu L, Peng H, Li X, Lin Y, Wang H, et al. Amiodarone-related pure red cell aplastic anemia and hypothyroidism in a child with total anomalous pulmonary venous connection. Front Pediatr. 2019;7:361.","journal-title":"Front Pediatr"},{"issue":"4","key":"644_CR38","first-page":"177","volume":"14","author":"MR Sabri","year":"2018","unstructured":"Sabri MR, Shoja M, Shoja M, Hosseinzadeh M. The effect of tadalafil on functional capacity and echocardiographic parameters in patients with repaired tetralogy of fallot. ARYA Atheroscler. 2018;14(4):177\u201382.","journal-title":"ARYA Atheroscler."},{"issue":"4","key":"644_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00246-018-1818-7","volume":"39","author":"Q Li","year":"2018","unstructured":"Li Q, Dimopoulos K, Zhang C, Zhu Y, Liu Q, Gu H. Acute effect of inhaled iloprost in children with pulmonary arterial hypertension associated with simple congenital heart defects. Pediatr Cardiol. 2018;39(4):757\u201362.","journal-title":"Pediatr Cardiol"},{"issue":"92\u20138","key":"644_CR40","volume":"199","author":"JH Heo","year":"2018","unstructured":"Heo JH, Rascati KL, Lopez KN, Moffett BS. Increased fracture risk with furosemide use in children with congenital heart disease. J Pediatr. 2018;199(92\u20138): e10.","journal-title":"J Pediatr"},{"issue":"2","key":"644_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00246-016-1529-x","volume":"38","author":"DT Truong","year":"2017","unstructured":"Truong DT, Johnson JT, Bailly DK, Clawson JR, Sheng X, Burch PT, et al. Platelet inhibition in shunted infants on aspirin at short and midterm follow-up. Pediatr Cardiol. 2017;38(2):401\u20139.","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"644_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/archdischild-2017-313654","volume":"103","author":"Y Singh","year":"2017","unstructured":"Singh Y, Mikrou P. Use of prostaglandins in duct-dependent congenital heart conditions. Arch Dis Child Educ Pract Ed. 2017;103(3):137\u201340.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"7","key":"644_CR43","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s00246-016-1421-8","volume":"37","author":"K Ueno","year":"2016","unstructured":"Ueno K, Ninomiya Y, Shiokawa N, Hazeki D, Eguchi T, Kawano Y. Dexmedetomidine is associated with an increased incidence of bradycardia in patients with trisomy 21 after surgery for congenital heart disease. Pediatr Cardiol. 2016;37(7):1228\u201334.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"644_CR44","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1213\/ANE.0000000000000869","volume":"122","author":"F Su","year":"2016","unstructured":"Su F, Gastonguay MR, Nicolson SC, DiLiberto M, Ocampo-Pelland A, Zuppa AF. Dexmedetomidine pharmacology in neonates and infants after open heart surgery. Anesthesia Analgesia. 2016;122(5):1556\u201366.","journal-title":"Anesthesia Analgesia."},{"issue":"6","key":"644_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/jhh.2015.87","volume":"30","author":"G Di Salvo","year":"2016","unstructured":"Di Salvo G, Castaldi B, Gala S, Baldini L, Del Gaizo F, D\u2019Aiello FA, et al. Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation. J Hum Hypertens. 2016;30(6):363\u20137.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"644_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00246-015-1251-0","volume":"37","author":"A Aykanat","year":"2016","unstructured":"Aykanat A, Yavuz T, Ozalkaya E, Topcuoglu S, Ovali F, Karatekin G. Long-term prostaglandin E1 infusion for newborns with critical congenital heart disease. Pediatr Cardiol. 2016;37(1):131\u20134.","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"644_CR47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00246-016-1343-5","volume":"37","author":"DE Amrousy","year":"2016","unstructured":"Amrousy DE, Elshehaby W, Feky WE, Elshmaa NS. Safety and efficacy of prophylactic amiodarone in preventing early junctional ectopic tachycardia (JET) in children after cardiac surgery and determination of Its risk factor. Pediatr Cardiol. 2016;37(4):734\u20139.","journal-title":"Pediatr Cardiol"},{"issue":"10","key":"644_CR48","first-page":"338","volume":"7","author":"Y Mekkhayai","year":"2015","unstructured":"Mekkhayai Y, Sornsuvit C, Preedisripipat K, Pongpittayut S. Effectiveness and safety of high dose oral ibuprofen versus standard dose for treatment of preterm infants with patent ductus arteriosus. Int J Pharm Pharm Sci. 2015;7(10):338\u201341.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"10","key":"644_CR49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/jp.2014.101","volume":"34","author":"T Soyer","year":"2014","unstructured":"Soyer T, Yalcin S, Bozkaya D, Yigit S, Tanyel FC. Transient hypertrophic pyloric stenosis due to prostoglandin infusion. J Perinatol. 2014;34(10):800\u20131.","journal-title":"J Perinatol"},{"issue":"2","key":"644_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/03009734.2013.778374","volume":"118","author":"T Perme","year":"2013","unstructured":"Perme T, Mali S, Vidmar I, Gvardijancic D, Blumauer R, Mishaly D, et al. Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis. Ups J Med Sci. 2013;118(2):138\u201342.","journal-title":"Ups J Med Sci."},{"issue":"2","key":"644_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pedneo.2012.10.007","volume":"54","author":"FK Huang","year":"2013","unstructured":"Huang FK, Lin CC, Huang TC, Weng KP, Liu PY, Chen YY, et al. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol. 2013;54(2):102\u20136.","journal-title":"Pediatr Neonatol"},{"issue":"5","key":"644_CR52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00246-012-0180-4","volume":"33","author":"S Takatsuki","year":"2012","unstructured":"Takatsuki S, Calderbank M, Ivy DD. Initial experience with tadalafil in pediatric pulmonary arterial hypertension. Pediatr Cardiol. 2012;33(5):683\u20138.","journal-title":"Pediatr Cardiol"},{"issue":"9","key":"644_CR53","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s12272-012-0919-8","volume":"35","author":"MJ Heo","year":"2012","unstructured":"Heo MJ, Lee OS, Lim SC. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus. Arch Pharm Res. 2012;35(9):1673\u201383.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"644_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12519-011-0252-1","volume":"7","author":"LH Tan","year":"2011","unstructured":"Tan LH, Du LZ, Carr MR, Kuzin JK, Moffett BS, Chang AC. Captopril induced reversible acute renal failure in a premature neonate with double outlet right ventricle and congestive heart failure. World J Pediatr. 2011;7(1):89\u201391.","journal-title":"World J Pediatr."},{"issue":"5","key":"644_CR55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2174\/157016111796642733","volume":"9","author":"V Bautista-Hernandez","year":"2011","unstructured":"Bautista-Hernandez V, Sanchez-Andres A, Portela F, Fynn-Thompson F. Current pharmacologic management of pediatric heart failure in congenital heart disease. Curr Vasc Pharmacol. 2011;9(5):619\u201328.","journal-title":"Curr Vasc Pharmacol"},{"issue":"8","key":"644_CR56","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00246-010-9790-x","volume":"31","author":"A Oxenius","year":"2010","unstructured":"Oxenius A, Hug MI, Dodge-Khatami A, Cavigelli-Brunner A, Bauersfeld U, Balmer C. Do predictors exist for a successful withdrawal of preoperative prostaglandin E(1) from neonates with d-transposition of the great arteries and intact ventricular septum? Pediatr Cardiol. 2010;31(8):1198\u2013202.","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"644_CR57","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00246-010-9772-z","volume":"31","author":"F N\u00fa\u00f1ez","year":"2010","unstructured":"N\u00fa\u00f1ez F, Ruiz-Granell R, Mart\u00ednez-Costa C, Morell S, Brines J. Safety and efficacy of flecainide in the treatment of symptomatic children with wolff-parkinson-white syndrome. Pediatr Cardiol. 2010;31(8):1162\u20135.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"644_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejcts.2010.01.045","volume":"38","author":"S Nemoto","year":"2010","unstructured":"Nemoto S, Sasaki T, Ozawa H, Katsumata T, Kishi K, Okumura K, et al. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children. Eur J Cardiothorac Surg. 2010;38(1):71\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"644_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/CIRCEP.109.901629","volume":"3","author":"PM Chang","year":"2010","unstructured":"Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. Circ Arrhythm Electrophysiol. 2010;3(2):134\u201340.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"644_CR60","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/0253-7613.55203","volume":"41","author":"SA Zaki","year":"2009","unstructured":"Zaki SA, Dadge D, Asif S, Shanbag P. Diagnostic dilemma in a child with congenital heart disease on sildenafil. Indian J Pharmacol. 2009;41(3):148\u20139.","journal-title":"Indian J Pharmacol."},{"issue":"1","key":"644_CR61","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpeds.2007.12.050","volume":"153","author":"L Mertens","year":"2008","unstructured":"Mertens L, Eyskens B, Boshoff D, Gewillig M. Safety and efficacy of clopidogrel in children with heart disease. J Pediatr. 2008;153(1):61\u20134.","journal-title":"J Pediatr"},{"issue":"5","key":"644_CR62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/JPM.2008.064","volume":"36","author":"MH Gantenbein","year":"2008","unstructured":"Gantenbein MH, Bauersfeld U, Baenziger O, Frey B, Neuhaus T, Sennhauser F, et al. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants. J Perinat Med. 2008;36(5):448\u201352.","journal-title":"J Perinat Med"},{"issue":"3","key":"644_CR63","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1442-200X.2007.02380.x","volume":"49","author":"G Talosi","year":"2007","unstructured":"Talosi G, Katona M, Turi S. Side-effects of long-term prostaglandin E(1) treatment in neonates. Pediatr Int. 2007;49(3):335\u201340.","journal-title":"Pediatr Int"},{"issue":"10","key":"644_CR64","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298(10):1171\u20139.","journal-title":"JAMA"},{"issue":"2","key":"644_CR65","doi-asserted-by":"publisher","first-page":"F117","DOI":"10.1136\/adc.2006.096305","volume":"92","author":"KA Browning Carmo","year":"2007","unstructured":"Browning Carmo KA, Barr P, West M, Hopper NW, White JP, Badawi N. Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F117\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"644_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00148581-200608010-00005","volume":"8","author":"K Momma","year":"2006","unstructured":"Momma K. ACE inhibitors in pediatric patients with heart failure. Paediatr Drugs. 2006;8(1):55\u201369.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"644_CR67","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00246-004-0863-6","volume":"26","author":"TC Slesnick","year":"2005","unstructured":"Slesnick TC, Mott AR, Fraser CD, Chang AC. Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease. Pediatr Cardiol. 2005;26(5):690\u20133.","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"644_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/sj.jp.7211050","volume":"24","author":"S Velaphi","year":"2004","unstructured":"Velaphi S, Cilliers A, Beckh-Arnold E, Mokhachane M, Mphahlele R, Pettifor J. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review. J Perinatol. 2004;24(4):263\u20135.","journal-title":"J Perinatol"},{"issue":"5","key":"644_CR69","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/01.PCC.0000137355.01277.9C","volume":"5","author":"M Turanlahti","year":"2004","unstructured":"Turanlahti M, Boldt T, Palkama T, Antila S, Lehtonen L, Pesonen E. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med. 2004;5(5):457\u201362.","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"644_CR70","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1515\/JPM.2004.069","volume":"32","author":"G Talosi","year":"2004","unstructured":"Talosi G, Katona M, Racz K, Kertesz E, Onozo B, Turi S. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects. J Perinat Med. 2004;32(4):368\u201374.","journal-title":"J Perinat Med"},{"issue":"5","key":"644_CR71","doi-asserted-by":"publisher","first-page":"F365","DOI":"10.1136\/fn.88.5.F365","volume":"88","author":"W Streif","year":"2003","unstructured":"Streif W, Goebel G, Chan AK, Massicotte MP. Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F365\u201370.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"644_CR72","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00467-003-1121-5","volume":"18","author":"S Dutta","year":"2003","unstructured":"Dutta S, Narang A. Enalapril-induced acute renal failure in a newborn infant. Pediatr Nephrol. 2003;18(6):570\u20132.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"644_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0167-5273(01)00413-2","volume":"79","author":"R Buchhorn","year":"2001","unstructured":"Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, B\u00fcrsch J. Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT trial. Int J Cardiol. 2001;79(2):167\u201373.","journal-title":"Int J Cardiol"},{"issue":"1","key":"644_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1046\/j.1525-1470.2000.01712.x","volume":"17","author":"EL Carter","year":"2000","unstructured":"Carter EL, Garzon MC. Neonatal urticaria due to prostaglandin E1. Pediatr Dermatol. 2000;17(1):58\u201361.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"644_CR75","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF02752297","volume":"65","author":"SC Reddy","year":"1998","unstructured":"Reddy SC, Saxena A. Prostaglandin E1: First stage palliation in neonates with congenital cardiac defects. Indian J Pediatr. 1998;65(2):211\u20136.","journal-title":"Indian J Pediatr"},{"key":"644_CR76","doi-asserted-by":"crossref","unstructured":"Janous\u0306ek J, Paul T. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Am J Card. 1998;81(9):1121\u20134.","DOI":"10.1016\/S0002-9149(98)00142-8"},{"issue":"6","key":"644_CR77","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1440-1754.1998.00310.x","volume":"34","author":"YF Cheung","year":"1998","unstructured":"Cheung YF, Leung MP. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease. J Paediatr Child Health. 1998;34(6):563\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"644_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF01953932","volume":"155","author":"AK Kalloghlian","year":"1996","unstructured":"Kalloghlian AK, Frayha HH, deMoor MM. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion. Eur J Pediatr. 1996;155(3):173\u20134.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"644_CR79","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/BF02276712","volume":"154","author":"HH Kramer","year":"1995","unstructured":"Kramer HH, Sommer M, Rammos S, Krogmann O. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease. Eur J Pediatr. 1995;154(9):700\u20137.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"644_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF00796991","volume":"14","author":"CA Ryan","year":"1993","unstructured":"Ryan CA, Robertson M, Coe JY. Seizures due to lidocaine toxicity in a child during cardiac catheterization. Pediatr Cardiol. 1993;14(2):116\u20138.","journal-title":"Pediatr Cardiol"},{"issue":"1\u20132","key":"644_CR81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000457536","volume":"20","author":"O Dagan","year":"1993","unstructured":"Dagan O, Peled N, Babin P, Silver M, Barker G, Koren G. Prostaglandin-induced antral hyperplasia in neonates: clinical experience and dose-response characteristics. Dev Pharmacol Ther. 1993;20(1\u20132):14\u20139.","journal-title":"Dev Pharmacol Ther"},{"issue":"8","key":"644_CR82","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0002-9149(92)90500-X","volume":"69","author":"P Maragnes","year":"1992","unstructured":"Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol. 1992;69(8):751\u20134.","journal-title":"Am J Cardiol"},{"issue":"8","key":"644_CR83","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0002-9149(91)90646-3","volume":"68","author":"A Reimer","year":"1991","unstructured":"Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias. Am J Cardiol. 1991;68(8):741\u20134.","journal-title":"Am J Cardiol"},{"issue":"4","key":"644_CR84","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/adc.63.4.360","volume":"63","author":"NJ Shaw","year":"1988","unstructured":"Shaw NJ, Wilson N, Dickinson DF. Captopril in heart failure secondary to a left to right shunt. Arch Dis Child. 1988;63(4):360.","journal-title":"Arch Dis Child"},{"issue":"1","key":"644_CR85","first-page":"100","volume":"142","author":"RE Shaddy","year":"1988","unstructured":"Shaddy RE, Teitel DF, Brett C. Short-term hemodynamic effects of captopril in infants with congestive heart failure. Am J Dis Child. 1988;142(1):100\u20135.","journal-title":"Am J Dis Child"},{"issue":"2","key":"644_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02387559","volume":"18","author":"A Host","year":"1988","unstructured":"Host A, Halken S, Andersen PE Jr. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease. Pediatr Radiol. 1988;18(2):149\u201353.","journal-title":"Pediatr Radiol"},{"issue":"3","key":"644_CR87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00716473","volume":"146","author":"BD Thanopoulos","year":"1987","unstructured":"Thanopoulos BD, Andreou A, Frimas C. Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease. Eur J Pediatr. 1987;146(3):279\u201382.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"644_CR88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0167-5273(87)90153-7","volume":"16","author":"AM Scammell","year":"1987","unstructured":"Scammell AM, Arnold R, Wilkinson JL. Captopril in treatment of infant heart failure: a preliminary report. Int J Cardiol. 1987;16(3):295\u2013301.","journal-title":"Int J Cardiol"},{"issue":"3","key":"644_CR89","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF02424990","volume":"7","author":"S Jureidini","year":"1986","unstructured":"Jureidini S, Chase NA, Alpert BS, Vanderzalm T, Sheneflet RE. Soft-tissue swelling in two neonates during prostaglandin E1 therapy. Pediatr Cardiol. 1986;7(3):157\u201360.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"644_CR90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02387508","volume":"16","author":"A Beitzke","year":"1986","unstructured":"Beitzke A, Stein J. Pseudo-widening of cranial sutures as a feature of long-term prostaglandin E1 therapy. Pediatr Radiol. 1986;16(1):57\u20138.","journal-title":"Pediatr Radiol"},{"issue":"5","key":"644_CR91","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/hrt.53.5.574","volume":"53","author":"S Westaby","year":"1985","unstructured":"Westaby S, Turner MW, Stark J. Complement activation and anaphylactoid repsonse to protamine in a child after cardiopulmonary bypass. Br Heart J. 1985;53(5):574\u20136.","journal-title":"Br Heart J"},{"issue":"11","key":"644_CR92","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/adc.60.11.1025","volume":"60","author":"ED Silove","year":"1985","unstructured":"Silove ED, Roberts DG, de Giovanni JV. Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease. Arch Dis Child. 1985;60(11):1025.","journal-title":"Arch Dis Child"},{"issue":"3","key":"644_CR93","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0735-1097(84)80262-4","volume":"3","author":"OH Teixeira","year":"1984","unstructured":"Teixeira OH, Carpenter B, MacMurray SB, Vlad P. Long-term prostaglandin E1 therapy in congenital heart defects. J Am Coll Cardiol. 1984;3(3):838\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"644_CR94","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/00007611-198408000-00027","volume":"77","author":"BS Alpert","year":"1984","unstructured":"Alpert BS, Jureidini SB, Vanderzalm T. Resolution of prostaglandin-induced cortical hyperostosis in an infant. South Med J. 1984;77(8):1039\u201340.","journal-title":"South Med J"},{"issue":"1","key":"644_CR95","first-page":"40","volume":"19","author":"RP Leitner","year":"1983","unstructured":"Leitner RP, Hawker RE, Celermajer JM. Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children. Aust Paediatr J. 1983;19(1):40\u20134.","journal-title":"Aust Paediatr J"},{"issue":"3","key":"644_CR96","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/j.1875-9114.1982.tb04522.x","volume":"2","author":"MA Heymann","year":"1982","unstructured":"Heymann MA, Clyman RI. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy. Pharmacotherapy. 1982;2(3):148\u201355.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"644_CR97","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/01.CIR.63.3.682","volume":"63","author":"ED Silove","year":"1981","unstructured":"Silove ED, Coe JY, Shiu MF, Brunt JD, Page AJ, Singh SP, et al. Oral prostaglandin E2 in ductus-dependent pulmonary circulation. Circulation. 1981;63(3):682\u20138.","journal-title":"Circulation"},{"issue":"5","key":"644_CR98","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.CIR.64.5.893","volume":"64","author":"AB Lewis","year":"1981","unstructured":"Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981;64(5):893\u20138.","journal-title":"Circulation"},{"issue":"12","key":"644_CR99","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/adc.56.12.934","volume":"56","author":"S Hobbins","year":"1981","unstructured":"Hobbins S, Fowler R, Rowe R, Korey A. Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch Dis Child. 1981;56(12):934\u20138.","journal-title":"Arch Dis Child"},{"issue":"5","key":"644_CR100","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S0022-3476(80)80282-4","volume":"97","author":"K Ueda","year":"1980","unstructured":"Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R, et al. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr. 1980;97(5):834\u20136.","journal-title":"J Pediatr"},{"issue":"6 Pt 2","key":"644_CR101","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0002-8703(80)90214-8","volume":"100","author":"P Coumel","year":"1980","unstructured":"Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980;100(6 Pt 2):1063\u20139.","journal-title":"Am Heart J"},{"issue":"3","key":"644_CR102","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0022-3476(78)81171-8","volume":"93","author":"AB Lewis","year":"1978","unstructured":"Lewis AB, Takahashi M, Lurie PR. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects. J Pediatr. 1978;93(3):481\u20135.","journal-title":"J Pediatr"},{"issue":"4","key":"644_CR103","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/S0022-3476(78)80911-1","volume":"93","author":"W Berman Jr","year":"1978","unstructured":"Berman W Jr, Dubynsky O, Whitman V, Friedman Z, Maisels MJ. Digoxin therapy in low-birth-weight infants with patent ductus arteriosus. J Pediatr. 1978;93(4):652\u20135.","journal-title":"J Pediatr"},{"issue":"2","key":"644_CR104","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/01.CIR.55.2.238","volume":"55","author":"JM Neutze","year":"1977","unstructured":"Neutze JM, Starling MB, Elliott RB, Barratt-Boyes BG. Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins. Circulation. 1977;55(2):238\u201341.","journal-title":"Circulation"},{"issue":"5","key":"644_CR105","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0090-6980(77)90219-2","volume":"13","author":"R Fariello","year":"1977","unstructured":"Fariello R, Olley PM, Coceani F. Neurological and electroencephalographic changes in newborns treated with prostaglandins E1 and E2. Prostaglandins. 1977;13(5):901\u20137.","journal-title":"Prostaglandins"},{"issue":"4","key":"644_CR106","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/01.CIR.53.4.728","volume":"53","author":"PM Olley","year":"1976","unstructured":"Olley PM, Coceani F, Bodach E. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations. Circulation. 1976;53(4):728\u201331.","journal-title":"Circulation"},{"issue":"10","key":"644_CR107","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJM197609022951003","volume":"295","author":"WF Friedman","year":"1976","unstructured":"Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295(10):526\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"644_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.13090","volume":"5","author":"AT Geanacopoulos","year":"2024","unstructured":"Geanacopoulos AT, Zielonka B, Fox MT, Kerr S, Chambers KD, Przybylski R, et al. Pediatric antiarrhythmics and toxicity: a clinical review. J Am Coll Emerg Physicians Open. 2024;5(1): e13090.","journal-title":"J Am Coll Emerg Physicians Open."},{"issue":"3","key":"644_CR109","first-page":"202","volume":"8","author":"IV Ramesh","year":"2008","unstructured":"Ramesh IV. Drug therapy considerations in arrhythmias in children. Indian Pacing Electrophysiol J. 2008;8(3):202\u201310.","journal-title":"Indian Pacing Electrophysiol J."},{"issue":"7","key":"644_CR110","first-page":"201","volume":"9","author":"CD Varela-Chinchilla","year":"2022","unstructured":"Varela-Chinchilla CD, S\u00e1nchez-Mej\u00eda DE, Trinidad-Calder\u00f3n PA. Congenital heart disease: the state-of-the-art on its pharmacological therapeutics. J Cardiovasc Dev Dis. 2022;9(7):201.","journal-title":"J Cardiovasc Dev Dis."},{"key":"644_CR111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2022.03.018","volume":"357","author":"M Brida","year":"2022","unstructured":"Brida M, Lovri\u0107 D, Griselli M, Riesgo Gil F, Gatzoulis MA. Heart failure in adults with congenital heart disease. Int J Cardiol. 2022;357:39\u201345.","journal-title":"Int J Cardiol"},{"issue":"2","key":"644_CR112","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ccep.2017.02.011","volume":"9","author":"T Contractor","year":"2017","unstructured":"Contractor T, Levin V, Mandapati R. Drug therapy in adult congenital heart disease. Card Electrophysiol Clin. 2017;9(2):295\u2013309.","journal-title":"Card Electrophysiol Clin."},{"key":"644_CR113","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/978-3-030-41967-7_29","volume-title":"Management of cardiac arrhythmias","author":"MM Lopez","year":"2020","unstructured":"Lopez MM, Kanter RJ. Arrhythmias in children and patients with congenital heart disease. In: Yan G-X, Kowey PR, Antzelevitch C, editors. Management of cardiac arrhythmias. Humana: Springer International Publishing; 2020. p. 671\u2013741."},{"issue":"4","key":"644_CR114","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ehjcvp\/pvz014","volume":"5","author":"OI Woudstra","year":"2019","unstructured":"Woudstra OI, Kuijpers JM, Meijboom FJ, Post MC, Jongbloed MRM, Duijnhouwer AL, et al. High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality. Eur Heart J Cardiovasc Pharmacother. 2019;5(4):216\u201325.","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"1","key":"644_CR115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ppedcard.2012.11.008","volume":"35","author":"C Escudero","year":"2013","unstructured":"Escudero C, Carr R, Sanatani S. Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children. Prog Pediatr Cardiol. 2013;35(1):55\u201363.","journal-title":"Prog Pediatr Cardiol"},{"issue":"5","key":"644_CR116","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00431-022-04768-2","volume":"182","author":"SAG Lava","year":"2023","unstructured":"Lava SAG, Zollinger C, Chehade H, Schaffner D, Sekarski N, Di Bernardo S. Diuretics in pediatrics. Eur J Pediatr. 2023;182(5):2077\u201388.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"644_CR117","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10741-020-10003-7","volume":"26","author":"PS Eid","year":"2021","unstructured":"Eid PS, Ibrahim DA, Zayan AH, Elrahman MMA, Shehata MAA, Kandil H, et al. Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials. Heart Fail Rev. 2021;26(1):127\u201336.","journal-title":"Heart Fail Rev"},{"key":"644_CR118","volume":"1","author":"S Alabed","year":"2016","unstructured":"Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev. 2016;1: CD007037.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"644_CR119","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/ped.14015","volume":"61","author":"VR Kaley","year":"2019","unstructured":"Kaley VR, Aregullin EO, Samuel BP, Vettukattil JJ. Trends in the off-label use of \u03b2-blockers in pediatric patients. Pediatr Int. 2019;61(11):1071\u201380.","journal-title":"Pediatr Int"},{"key":"644_CR120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcmd.2017.05.008","volume":"67","author":"M Hepponstall","year":"2017","unstructured":"Hepponstall M, Chan A, Monagle P. Anticoagulation therapy in neonates, children and adolescents. Blood Cells Mol Dis. 2017;67:41\u20137.","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"644_CR121","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2141.2010.08225.x","volume":"150","author":"JH Payne","year":"2010","unstructured":"Payne JH. Aspects of anticoagulation in children. Br J Haematol. 2010;150(3):259\u201377.","journal-title":"Br J Haematol"},{"issue":"4","key":"644_CR122","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40272-020-00403-5","volume":"22","author":"C George","year":"2020","unstructured":"George C, Rahman M, Monagle P. Challenges and opportunities in the pharmacological treatment of acute venous thromboembolism in children. Paediatr Drugs. 2020;22(4):385\u201397.","journal-title":"Paediatr Drugs"},{"issue":"11","key":"644_CR123","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00467-019-04314-7","volume":"35","author":"N Siddiqi","year":"2020","unstructured":"Siddiqi N, Shatat IF. Antihypertensive agents: a long way to safe drug prescribing in children. Pediatr Nephrol. 2020;35(11):2049\u201365.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"644_CR124","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10557-017-6733-2","volume":"31","author":"HK Flaten","year":"2017","unstructured":"Flaten HK, Monte AA. The pharmacogenomic and metabolomic predictors of ACE inhibitor and angiotensin II receptor blocker effectiveness and safety. Cardiovasc Drugs Ther. 2017;31(4):471\u201382.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"644_CR125","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.jvca.2023.11.020","volume":"38","author":"E Pilia","year":"2024","unstructured":"Pilia E, Silvetti S, Bohane SM, Pusceddu E, Belletti A. Safety of levosimendan in pediatric patients: an up-to-date systematic review. J Cardiothorac Vasc Anesth. 2024;38(3):820\u20138.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"644_CR126","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2017.10.077","volume":"251","author":"A Putzu","year":"2018","unstructured":"Putzu A, Clivio S, Belletti A, Cassina T. Perioperative Levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis. Int J Cardiol. 2018;251:22\u201331.","journal-title":"Int J Cardiol"},{"issue":"1","key":"644_CR127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jped.2021.05.008","volume":"98","author":"Q Wang","year":"2022","unstructured":"Wang Q, Chen C, Wang L. Efficacy and safety of dexmedetomidine in maintaining hemodynamic stability in pediatric cardiac surgery: a systematic review and meta-analysis. J Pediatr (Rio J). 2022;98(1):15\u201325.","journal-title":"J Pediatr (Rio J)"},{"issue":"3","key":"644_CR128","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/pan.12820","volume":"26","author":"W Pan","year":"2016","unstructured":"Pan W, Wang Y, Lin L, Zhou G, Hua X, Mo L. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis. Paediatr Anaesth. 2016;26(3):239\u201348.","journal-title":"Paediatr Anaesth"},{"key":"644_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.668902","volume":"12","author":"T Shu","year":"2021","unstructured":"Shu T, Chen H, Wang L, Wang W, Feng P, Xiang R, et al. The efficacy and safety of pulmonary vasodilators in pediatric pulmonary hypertension (PH): a systematic review and meta-analysis. Front Pharmacol. 2021;12: 668902.","journal-title":"Front Pharmacol"},{"issue":"9","key":"644_CR130","first-page":"1572","volume":"10","author":"N Ofek Shlomai","year":"2023","unstructured":"Ofek Shlomai N, Lazarovitz G, Koplewitz B, Eventov FS. Cumulative dose of Prostaglandin E1 determines gastrointestinal adverse effects in term and near-term neonates awaiting cardiac surgery: a retrospective cohort study. Children (Basel). 2023;10(9):1572.","journal-title":"Children (Basel)."},{"issue":"2","key":"644_CR131","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1573396317666210219162515","volume":"17","author":"A Taksande","year":"2021","unstructured":"Taksande A, Jameel PZ. Critical congenital heart disease in neonates: a review article. Curr Pediatr Rev. 2021;17(2):120\u20136.","journal-title":"Curr Pediatr Rev"},{"issue":"2","key":"644_CR132","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40746-020-00193-5","volume":"6","author":"D Yacob","year":"2020","unstructured":"Yacob D, Di Lorenzo C. Constipation in children: a guide to prompt diagnosis and effective treatment. Curr Treat Options Pediatr. 2020;6(2):101\u201315.","journal-title":"Curr Treat Options Pediatr."},{"issue":"17","key":"644_CR133","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.jacc.2021.03.012","volume":"77","author":"G-P Diller","year":"2021","unstructured":"Diller G-P, Arvanitaki A, Opotowsky AR, Jenkins K, Moons P, Kempny A, et al. Lifespan perspective on congenital heart disease research: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(17):2219\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"644_CR134","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.amjcard.2020.05.011","volume":"129","author":"JB Kostis","year":"2020","unstructured":"Kostis JB, Dobrzynski JM. Limitations of randomized clinical trials. Am J Card. 2020;129:109\u201315.","journal-title":"Am J Card"},{"key":"644_CR135","first-page":"199","volume-title":"Cardiovascular survey methods","author":"RV Luepker","year":"2004","unstructured":"Luepker RV, Evans A, McKeigue P, Reddy KS. Cardiovascular survey methods. 3rd ed. Geneva: World Health Organization; 2004. p. 199.","edition":"3"},{"issue":"9","key":"644_CR136","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/bcp.14024","volume":"85","author":"TM Caparrotta","year":"2019","unstructured":"Caparrotta TM, Dear JW, Colhoun HM, Webb DJ. Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision-making. Br J Clin Pharmacol. 2019;85(9):1907\u201324.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"644_CR137","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.cjca.2021.06.013","volume":"37","author":"KC Harris","year":"2021","unstructured":"Harris KC, Mackie AS, Dallaire F, Khoury M, Singer J, Mahle WT, et al. Unique challenges of randomised controlled trials in pediatric cardiology. Can J Cardiol. 2021;37(9):1394\u2013403.","journal-title":"Can J Cardiol"},{"key":"644_CR138","doi-asserted-by":"crossref","unstructured":"Raj N, Fernandes S, Charyulu NR, Dubey A, G. S R, Hebbar S. Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada. Ther Adv Drug Saf. 2019;10:2042098619865413.","DOI":"10.1177\/2042098619865413"},{"issue":"1","key":"644_CR139","first-page":"25","volume":"37","author":"A Dang","year":"2023","unstructured":"Dang A. Real-world evidence: a primer. Pharmaceut Med. 2023;37(1):25\u201336.","journal-title":"Pharmaceut Med."},{"issue":"1","key":"644_CR140","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ahj.2010.08.032","volume":"161","author":"WW Lai","year":"2011","unstructured":"Lai WW, Vetter VL, Richmond M, Li JS, Saul JP, Mital S, et al. Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J. 2011;161(1):13\u201367.","journal-title":"Am Heart J"},{"issue":"6","key":"644_CR141","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jdiacomp.2013.07.007","volume":"27","author":"EJ Boyko","year":"2013","unstructured":"Boyko EJ. Observational research\u2013opportunities and limitations. J Diabetes Complicat. 2013;27(6):642\u20138.","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"644_CR142","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ahj.2012.07.019","volume":"164","author":"KE Bates","year":"2012","unstructured":"Bates KE, Vetter VL, Li JS, Cummins S, Aguel F, Almond C, et al. Pediatric cardiovascular safety: challenges in drug and device development and clinical application. Am Heart J. 2012;164(4):481\u201392.","journal-title":"Am Heart J"},{"key":"644_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.798215","volume":"8","author":"J Van den Eynde","year":"2021","unstructured":"Van den Eynde J, Manlhiot C, Van De Bruaene A, Diller GP, Frangi AF, Budts W, et al. Medicine-based evidence in congenital heart disease: how artificial intelligence can guide treatment decisions for individual patients. Front Cardiovasc Med. 2021;8: 798215.","journal-title":"Front Cardiovasc Med."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00644-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:20:19Z","timestamp":1724293219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00644-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":143,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00644-8","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"30 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was funded and supported by the Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran (1402-2-113-26934).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data represented are available in the public domain.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This study was performed in line with the principles of the declaration of Helsinki. Ethics approval was granted by Iran University of Medical Sciences (IR.IUMS.REC.1401.1007).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed upon the publication of this manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization was performed by E.T. and H.A.; methodology was planned by E.T. and H.A.; validation was carried out by R.A and A.F.S; formal analysis was carried out by E.T.; investigation was performed by E.T.; writing\u2014original draft was performed by E.T.; writing\u2014review and editing was carried out by E.T. and H.A.; supervision was performed by H.A. All authors have read and agreed to publish the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}